How we prove a vitamin K2 MK-7 lot is the all-trans isomer
A vitamin K2 MK-7 lot (CAS 2124-57-4, C46H64O2) is identified in four layers: the certificate and the lot chain, the chromatographic identity, the isomer ratio and homologue profile, and the carrier with its mass balance. A total MK-7 assay on its own cannot separate all-trans MK-7 from a cis-rich material, a different menaquinone or a powder that has been diluted further than the label says. The all-trans figure is the identity check that belongs specifically to this grade.
A total MK-7 assay can pass while the isomer ratio fails; identity needs the chromatogram, the all-trans figure and the carrier.
The four layers of identity
| Layer | Evidence | What it proves | What it does not prove |
|---|---|---|---|
| Documentary | COA, lot code, source statement, specification | The lot in the pack is the lot in the file | That the chemistry matches the file |
| Chromatographic | Retention time, UV spectrum, standard addition | The peak is menaquinone-7 | The isomer ratio, unless the method resolves it |
| Isomeric | all-trans and cis peak areas, homologue profile | The configuration and the menaquinone distribution | The carrier or the dilution |
| Matrix | Carrier declaration, mass balance, LOD | The powder is the grade that was ordered | The identity of the MK-7 on its own |
A certificate can be genuine and still describe a different lot; a chromatogram can show one peak and still hide cis isomers if the method does not resolve them; a correct MK-7 peak can sit in a powder whose carrier is not the one declared. Identity is the four layers agreeing, not one layer being present.
What the HPLC has to show
MK-7 is normally determined by reversed-phase HPLC with UV detection and an external reference standard. The retention time establishes the peak; a diode-array spectrum and a standard addition make the assignment stronger. The method has to resolve the all-trans peak from the cis isomers, because the isomer ratio is calculated from the peak areas, not from the total.
Ask for the chromatogram, the column, the mobile phase, the detection wavelength and the integration parameters. The chromatogram should show the all-trans peak, the cis region and the reference standard run under the same conditions.
LC-MS is useful when the peak assignment is disputed: the molecular ion separates MK-7 from MK-4, MK-6, MK-8 and MK-9.
The all-trans ratio and the other menaquinones
The catalog specification requires at least 92% of the MK-7 to be the all-trans isomer. The remainder is mainly cis isomers, and the ratio is a record of how the material was processed and stored: heat and light convert trans double bonds to cis, so a low all-trans figure points to an exposure that a total assay cannot see. The EU entry's synthetic specification caps cis isomers at 6.0%; a 1% powder sold into the EU still has to show that its MK-7 meets the entry route that applies to it, not only the powder's all-trans floor.
Other menaquinones also occur. The EU entry describes a material that is primarily MK-7 with a smaller amount of MK-6, so MK-6 is not automatically an adulterant; it is a component whose limit should be stated. MK-4, MK-8 and MK-9 are different questions. A specification that says only "MK-7 ≥1%" leaves the homologue profile and the cis content open.
The carrier is part of the identity
In a 1% spray-dried powder, about 99% of the mass is not MK-7. The carrier is starch or gum arabic, and it must be named on the certificate. The mass balance should close: MK-7 content, loss on drying, carrier and minor components add up to 100%. A certificate that quotes 98% for a 1% powder is confusing the powder with the isolated ingredient.
The carrier can also interfere with identity tests. Microscopy sees starch granules or gum particles, not the molecule; FTIR sees the matrix as well as the menaquinone. The method has to account for the matrix, and the specification must state the carrier so a change of carrier is a change of product; without that declaration the mass balance cannot be audited.
What XRD can and cannot see in a 1% powder
X-ray diffraction reads crystalline phases, and in a 1% spray-dried powder any crystalline phase belongs to the carrier, not the menaquinone. Starch returns its own sharp reflections, while gum arabic and the spray-dried matrix are largely amorphous. MK-7 dispersed at 1% sits far below the few-percent detection limit that a phase scan can reach in this matrix, so an XRD pattern cannot confirm the molecule, cannot measure the content and cannot separate all-trans from cis.
For the isolated crystalline MK-7 a diffraction pattern is a legitimate solid-form check, but it is not the identity test a buyer needs. The identity evidence is the HPLC retention time and ultraviolet spectrum, the all-trans and cis peak areas, the homologue profile by LC-MS and the carrier mass balance. An XRD report on a finished powder is not a substitute for any of them.
The routes that pass a total assay
| Route | What still passes | What catches it |
|---|---|---|
| MK-4 substituted or added | A broad "vitamin K2" assay | Retention time, UV spectrum, LC-MS |
| Other menaquinones | Total menaquinone figure | Homologue profile, mass detection |
| Lower MK-7 content | Appearance and a nominal grade name | Content assay, mass balance, carrier ratio |
| Cis-rich material | Total MK-7 content | all-trans and cis peak areas |
| Undeclared carrier or spiking | MK-7 content inside 0.9–1.1% | Carrier declaration, mass balance, microscopy |
Each route is designed to satisfy the headline number, so the defence is to specify the headline number and the supporting evidence together: content, isomer ratio, homologue profile, carrier and lot traceability.
How to write the identity specification
Write the full name and the source: "Menaquinone-7 (all-E), 1% spray-dried powder, synthetic or Bacillus fermentation, source declared." Then the analytical lines: "Identification by HPLC retention time and UV spectrum against a reference standard; MK-7 0.9–1.1%; all-trans ≥92% of MK-7; cis isomers reported; other menaquinones reported against an agreed limit; carrier starch or gum arabic, named; loss on drying ≤5.0%; ≥95% through 40 mesh."
Add the negative statement that matters: "No menadione added; no MK-4 added; no undeclared carrier." A negative statement is only useful if the method can detect the substance, so pair it with the test that would catch it, and state whether the content results are on an as-is or dried basis.
Five questions for the supplier
- Which MK-7 result and which all-trans result belong to this lot, and what method, column and wavelength produced them?
- Can you send the chromatogram that shows the cis peaks and the integration?
- Is the MK-7 synthetic or fermentation-derived, and does the certificate state the source?
- What is the carrier, at what proportion, and is it the only diluent?
- Which other menaquinones were screened, at what limit, and was menadione included?
Five direct answers amount to an identity file. The product page carries the catalog specification; the COA page explains each figure; the grade page explains the concentration; the compliance page covers the source and the label. The HPLC method note explains the separation, and the assay glossary entry defines the basis.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation